p53 suppression would be an important therapeutic target because it is activated in human ALS [63] and in rodent models of MN degeneration [113,114,115]; furthermore, p53 appears to be a strong driver of adult MN apoptosis [114,115]. This evidence concerns the gene TP53 and amyotrophic lateral sclerosis.